Pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document considers the implication of pharmacokinetics/pharmacodynamics relationship for the development of antibacterial medicinal products.
Keywords: Pharmacokinetics (PK), pharmacodynamics (PD), PK/PD model, antibacterial medicinal product
Current effective version
Related content
- Clinical efficacy and safety: clinical pharmacology and pharmacokinetics
Questions and answers: Positions on specific questions addressed to the Pharmacokinetics Working Party- ICH E4 Dose response information to support drug registration
- Investigation of bioequivalence
- Pharmacokinetic studies in man